Geoffrey M. Glass

Geoffrey M. Glass has been a member of the Avadel Board of Directors since July 2018 and became Chairman of the Board in December 2018. Geoff is the founder and Chief Executive Officer of Kiniciti, a company focused on accelerating the advancement of the cell and gene therapy sector. Geoff has spent over 25 years helping lead services and therapeutic companies in the life sciences sector, including as an Operating Partner at LongueVue Capital, Chief Executive Officer of Sancilio Pharmaceuticals, and as a President at Patheon. Before Patheon, Geoff served on Valeant Pharmaceutical’s (now Bausch Health’s) executive team for nearly five years, first as Chief Information Officer and then running the company’s Asia business. Geoff received a BA in economics and political science from the University of Arizona.